Hans H. Maurer

Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry

Markus R. Meyer, J. Wilhelm, Frank T. Peters et al. · Analytical and Bioanalytical Chemistry · 2010 · 270 citations

Pharmacy, Pharmacology, Toxicology +15

Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (‘Ecstasy’)

Hans H. Maurer, Joerg Bickeboeller-Friedrich, Frank T. Peters · Toxicology Letters · 2000 · 206 citations

Pharmacy, Pharmacology, Toxicology +13

Studies on the metabolism of the α‐pyrrolidinophenone designer drug methylenedioxy‐pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC–MS and LC–high‐resolution MS and its detectability in urine by GC–MS

Markus R. Meyer, Peng Du, Frank Schuster et al. · Journal of Mass Spectrometry · 2010 · 186 citations

Medicine, Clinical Toxicology, Toxicology +17

Screening for and validated quantification of amphetamines and of amphetamine‐ and piperazine‐derived designer drugs in human blood plasma by gas chromatography/mass spectrometry

Frank T. Peters, Simone Schaëfer, Roland F. Staack et al. · Journal of Mass Spectrometry · 2003 · 171 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +13

Screening, library‐assisted identification and validated quantification of 23 benzodiazepines, flumazenil, zaleplone, zolpidem and zopiclone in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization

Carsten Kratzsch, Oliver Tenberken, Armin Weber et al. · Journal of Mass Spectrometry · 2004 · 156 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +16